搜索页_+Trastuzumab+emtansine

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“Elsevier电子期刊”中，命中：23条，耗时：小于0.01 秒

在所有数据库中总计命中：262条

1.Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)

作者：Alessandro D. Santin^a ; ^{alessandro.santin@yale.edu} ; Stefania Bellone^a ; Natalia Buza^b ; Peter E. Schwartz^a

关键词：Uterine serous carcinoma ; Trastuzumab-emtansine ; HER2/neu

刊名：Gynecologic Oncology Reports

出版年：2017

2.Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol

作者：Kadoaki Ohashi¹ ; ^{kohashi@cc.okayama-u.ac.jp} ; Katsuyuki Hotta² ; Taizo Hirata² ; Keisuke Aoe³ ; Toshiyuki Kozuki⁴ ; Kiichiro Ninomiya⁵ ; Hiroe Kayatani⁵ ; Hiroyuki Yanai⁶ ; Shinichi Toyooka⁷ ; Shiro Hinotsu² ; Minoru Takata⁸ ; Katsuyuki Kiura¹

关键词：HER2 amplification ; HER2 mutations ; HER2 over-expression ; NSCLC ; Trastuzumab emtansine

刊名：Clinical Lung Cancer

出版年：2017

3.Trastuzumab emtansine and cost-based decision making

作者：The Lancet

刊名：The Lancet

出版年：2017

4.Trastuzumab emtansine associated nodular regenerative hyperplasia: A case report and review of literature

作者：L.H. Prochaska ; I. Damjanov ; R.M. Ash ; J.C. Olson ; Q.J. Khan ; P. Sharma ; ^{psharma2@kmuc.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：T-DM1 ; Trastuzumab emtansine ; MCC ; 4-[N-maleimidomethyl] cyclohexane-1 carboxylate ; HER2 ; human epidermal growth receptor-2 ; DM-1 ; emtansine ; NRH ; nodular regenerative hyperplasia ; ER ; estrogen receptor ; PR ; progesterone recepton ; TCH ; docetaxel ; carboplatin ; Herceptin chemotherapy regimen ; NCPH ; noncirrhotic portal hypertension

刊名：Cancer Treatment Communications

出版年：2016

5.Multiple heart-cutting and comprehensive two-dimensional liquid chromatography hyphenated to mass spectrometry for the characterization of the antibody-drug conjugate ado-trastuzumab emtansine

作者：Koen Sandra^a ; ^{koen.sandra@richrom.com" class="auth_mail" title="E-mail the corresponding author} ; Gerd Vanhoenacker^a ; Isabel Vandenheede^a ; Mieke Steenbeke^a ; Maureen Joseph^b ; Pat Sandra^a

关键词：Antibody-drug conjugate ; Ado-trastuzumab emtansine ; Two-dimensional liquid chromatography ; Multiple heart-cutting ; Comprehensive

刊名：Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences

出版年：2016

6.Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series

作者：Kevin C. Keith^a ; ^{kevin_keith@med.unc.edu" class="auth_mail" title="E-mail the corresponding author} ; Yueh Lee^b ; ^c ; Matthew G. Ewend^c ; ^d ; Timothy M. Zagar^c ; ^d ; ^e ; Carey K. Anders^c ; ^f ; ^{Carey_anders@med.unc.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：Breast cancer ; Brain metastasis ; T-DM1 ; Kadcyla ; Adotrastuzumab ; Emtansine

刊名：Cancer Treatment Communications

出版年：2016

7.Current challenges in HER2-positive breast cancer

作者：Fabio Puglisi^a ; ^b ; ^{fabio.puglisi@uniud.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Caterina Fontanella^a ; ^b ; Vito Amoroso^c ; Giulia Valeria Bianchi^d ; Giancarlo Bisagni^e ; Cristina Falci^f ; Andrea Fontana^g ; Daniele Generali^h ; Lorenzo Gianniⁱ ; Antonio Grassadonia^j ; Luca Moscetti^k ; Ilaria Portarena^l ; Emanuela Rossi^m ; Paolo Marchettiⁿ

关键词：Breast cancer ; Dual targeting ; HER2 ; Lapatinib ; Neoadjuvant ; Pertuzumab ; Trastuzumab ; Trastuzumab-emtansine

刊名：Critical Reviews in Oncology and Hematology

出版年：2016

8.Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA’s Office of Pharmaceutical Quality

作者：Adam C. Fisher^a ; Sau L. Lee^a ; ^{sau.lee@fda.hhs.gov} ; Daniel P. Harris^a ; Lucinda Buhse^a ; Steven Kozlowski^a ; Lawrence Yu^a ; Michael Kopcha^a ; Janet Woodcock^b

关键词：ADF ; abuse deterrent formulation ; API ; active pharmaceutical ingredient ; T-DM1 ; Ado-Trastuzumab Emtansine ; ADC ; antibody-drug conjugate ; CDER ; center for drug evaluation and research ; CBRN/EID ; chemical ; biological ; radiological/nuclear and emerging infectious disease ; CMC ; chemistry ; manufacturing ; and controls ; DMD ; Duchenne muscular dystrophy ; DLS ; dynamic light scattering ; FDA ; food and drug administration ; FTIR ; Fourier transform infrared spectroscopy ; GA ; glatiramer acetate ; IVIVC ; in vivo

刊名：International Journal of Pharmaceutics

出版年：2016

9.Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature

作者：Marí ; a Teresa Martí ; nez^a ; ^{maitemartinez3@yahoo.es" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; José ; Alejandro Pé ; rez-Fidalgo^bAuthor Vitae ; Paloma Martí ; n-Martorell^bAuthor Vitae ; Juan Miguel Cejalvo^bAuthor Vitae ; Vanesa Pons^bAuthor Vitae ; Begoñ ; a Bermejo^bAuthor Vitae ; Miguel Martí ; n^cAuthor Vitae ; Joan Albanell^dAuthor Vitae ; Ana Lluch^b ; ^{lluch_ana@gva.es" class="auth_mail" title="E-mail the corresponding author}Author Vitae

关键词：Advanced Breast cancer ; Her2 positive ; Treatment ; Trastuzumab emtansine

刊名：Critical Reviews in Oncology and Hematology

出版年：2016

10.Trastuzumab emtansine for HER2-positive breast cancer

作者：Priya Venkatesan

刊名：The Lancet Oncology

出版年：2016

按检索点细分(23)

题名(13)

关键词(11)

文摘(14)

按出版年细分(23)

2027年及以后(6)

2017年(3)

2016年(10)

2013年(3)

2000年及以前(1)